GECo: Implementation and Effectiveness of COPD Self Management Action Plans in Low and Middle Income Countries
GECo2
Global Excellence in COPD Outcomes: Implementation and Effectiveness of COPD Self-Management Action Plans in Low and Middle Income Countries
1 other identifier
interventional
240
3 countries
3
Brief Summary
This study will randomise people with clinically significant COPD (GOLD Grade B-D) to usual care or provision of a self-management action plan supported by monthly follow-up visits from a community health worker trained in the use of the action plan. The primary outcome will be health-status: a comparison of the change in St. George's Respiratory Questionnaire (SGRQ) between baseline and 12 months in the two groups. We will randomise 240 people from three low- and middle-income countries, namely Nepal, Peru and Uganda. We will also examine the feasibility of implementing our self-management action plan intervention at scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable chronic-obstructive-pulmonary-disease
Started Dec 2017
Typical duration for not_applicable chronic-obstructive-pulmonary-disease
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 27, 2017
CompletedStudy Start
First participant enrolled
December 1, 2017
CompletedFirst Posted
Study publicly available on registry
December 2, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2020
CompletedDecember 4, 2017
December 1, 2017
1.9 years
November 27, 2017
December 1, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in SGRQ
Comparison of the change in SGRQ between baseline and 12 months, in the intervention compared to the control arm. b) Implementation Aim 1: Assess the appropriateness, acceptability and feasibility of using questionnaires and PEF to identify COPD cases from the perspective of local community members, community health workers, local health centre physicians and ministries of health.
12 months
Secondary Outcomes (4)
Number of Exacerbations
12 months
Number of Hospitalisations
12 months
Number of CHW visits
12 months
Health-Economics
12 months
Study Arms (2)
Intervention Group
EXPERIMENTALPatient education in use of a COPD self-management action plan supported by monthly visits from, and access to, a CHW who has been trained in the use of a COPD self-management action plan.
Control Group
NO INTERVENTIONCOPD 'standard' care in local setting - Bhaktapur, Nepal; Lima, Peru; Nakaseke, Uganda
Interventions
Patient education in use of a COPD self-management action plan supported by monthly visits from, and access to, a CHW who has been trained in the use of a COPD self-management action plan.
Eligibility Criteria
You may qualify if:
- Male or female participants aged ≥40 years
- Full-time resident in the area (living in area \> 6 months)
- Able to perform adequate quality spirometry
- Capable of providing informed consent
- Identified as having COPD grade B-D as per GOLD criteria
You may not qualify if:
- Pregnancy (self-reported)
- Currently has active pulmonary TB or is taking medications for pulmonary TB
- Identified as having COPD grade A as per GOLD criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University College, Londonlead
- Johns Hopkins Universitycollaborator
- Universidad Peruana Cayetano Herediacollaborator
- Asociacion Benefica Prismacollaborator
- Makerere Universitycollaborator
- University of Yorkcollaborator
- Institute of Medicine, Tribhuvan University, Nepalcollaborator
Study Sites (3)
Institute of Medicine
Kathmandu, Nepal
Universidad Peruana Cayetano Heredia
Lima, Peru
Makerere University Lung Institute
Makerere, Uganda
Related Publications (2)
Pollard SL, Siddharthan T, Hossen S, Rykiel NA, Flores-Flores O, Alupo P, Quaderi S, Ascencio I, Barber JA, Chandyo R, Das SK, Gianella G, Kirenga B, Grunstra K, Miranda JJ, Mohan S, Ricciardi F, Sharma AK, Shrestha L, Soares MO, Wosu AC, Hurst JR, Checkley W; GECo2 Trial Investigators. Chronic Obstructive Pulmonary Disease Self-Management in Three Low- and Middle-Income Countries: A Pilot Randomized Trial. Am J Respir Crit Care Med. 2023 Nov 15;208(10):1052-1062. doi: 10.1164/rccm.202303-0505OC.
PMID: 37698443DERIVEDSiddharthan T, Pollard SL, Quaderi SA, Mirelman AJ, Cardenas MK, Kirenga B, Rykiel NA, Miranda JJ, Shrestha L, Chandyo RK, Cattamanchi A, Michie S, Barber J, Checkley W, Hurst JR; GECo Study Investigators. Effectiveness-implementation of COPD case finding and self-management action plans in low- and middle-income countries: global excellence in COPD outcomes (GECo) study protocol. Trials. 2018 Oct 19;19(1):571. doi: 10.1186/s13063-018-2909-8.
PMID: 30340648DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John R Hurst, FRCP, PhD
University College, London
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 27, 2017
First Posted
December 2, 2017
Study Start
December 1, 2017
Primary Completion
November 1, 2019
Study Completion
February 1, 2020
Last Updated
December 4, 2017
Record last verified: 2017-12
Data Sharing
- IPD Sharing
- Will not share